Vacancy - Bioinformatics Developer/Scientist

The Wellcome Centre for Cell Biology is seeking a skilled bioinformatician to join our bioinformatics core facility. Further details are on our recruitment page (https://www.wcb.ed.ac.uk/recruitment) and on the University jobs webpage: https://www.ed.ac.uk/human-resources/jobs  (Vacancy Ref: 048373).

The post is fixed term until 30 November 2021.   Apply online at https://www.ed.ac.uk/human-resources/jobs. Vacancy Ref: 048373 . Closing Date: 22 July 2019, 5.00pm.

Informal enquiries are welcome and should be directed to Shaun Webb, Bioinformatics Facilty Manager (Shaun.Webb@ed.ac.uk)


 

Recent Research Papers

Welcome to Cell Biology

The Centre for Cell Biology is one of fifteen UK-based Wellcome Trust Centres, three of which are in Scotland. We were granted full Centre status by the Wellcome Trust in 2001, the year that the draft human genome was published.

Our mission is to play a significant part of the scientific global endeavour aimed at understanding living systems at the molecular level, making discoveries that advance knowledge of normal and abnormal cell function.

We currently specialise in the following areas: 1) the synthesis, processing, localisation and degradation of RNA; 2) epigenetic control of chromosome function; 3) mechanisms of cell growth & duplication; 4) the rules that govern cellular architecture.

Our research is “investigator-led”; in other words, the Centre’s scientific progress depends on the ingenuity and curiosity of its research group leaders, each of whom follows their own instincts.

Adele Marston elected to EMBO

On 11 June, EMBO announced that Adele Marston has been elected to its membership.  She joins a group of the best life science researchers in Europe and around the world.

EMBO Members actively participate in the execution of the organisation’s initiatives by serving on Council, committees and editorial boards, by evaluating applications for EMBO funding, by mentoring young scientists and by providing suggestions and feedback on activities.

Latest findings could lead to development of new drugs to treat Acute Myeloid Leukaemia

Research into the role of the protein, YTHDF2, in Acute Myeloid Leukaemia (AML) has identified YTHDF2 as a promising drug target for the treatment of AML.  

The role of YTHDF2 in AML was investigated by a team of researchers led by Dónal O’Carroll (WCB & CRM, University of Edinburgh) and Kamil Kranc (Queen Mary University of London).

Dónal O’Carroll to become a Fellow of the Royal Society of Edinburgh

On Friday 1 March 2019, the Royal Society of Edinburgh (RSE) announced that Dónal O’Carroll is one of 62 new fellows who will be inducted in May 2019.

He will join the existing Fellowship of over 1600 individuals who have a diverse breadth of knowledge and experience in areas including business, science, creative arts, health, technology, law, public engagement and international development.  They give their time and expertise for free to support the RSE in delivering its mission of ‘knowledge made useful’.

Jean Beggs Awarded RNA Society 2018 Life Time Achievement Award

It has been announced that Jean Beggs is the recipient of the 2018 Lifetime Achievement Award from the RNA Society.  This will be formally awarded at the RNA Society meeting in Berkley, California, USA, in May-June 2018. The award recognises her work on yeast splicing and transcription and her contribution to the understanding of the yeast splicing machinery.